Search | TVST | ARVO Journals

tvst

Issues
Topics
For Authors
About
- Editorial Board

Journals Home

MANAGE ALERTS

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board

Narrow View

NARROW

Content Type

Journal Articles (2)
Meeting Abstract (1)

Journal

Translational Vision Science & Technology (2)
Investigative Ophthalmology & Visual Science (1)

Article Type

Retina (2)
ARVO Annual Meeting Abstract (1)

Topics

Pharmacology (2)
Translational Research (2)

Tags

faricimab (2)
hypertension (2)
diabetic macular edema (1)
exudative age-related macular degeneration (1)
intravitreal injections (1)
pharmacodynamics (1)
pharmacokinetics (1)
plasma (1)
retinal diseases (1)
vascular endothelial growth factor a (1)

Specify Date Range

From: To: Apply

Showing 1 – 3 of 3

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina November 2024

Ocular Pharmacokinetics of Faricimab Following Intravitreal Administration in Patients With Retinal Disease

PDF

Cheikh Diack; Leonid Gibiansky; Felix Jaminion; Ekaterina Gibiansky; Jacques Gaudreault; Katrijn Bogman; Valerie Cosson
TAGS: faricimab, intravitreal injections, retinal diseases, pharmacokinetics, hypertension, plasma
Trans. Vis. Sci. Tech.. 2024; 13(11):14. https://doi.org/10.1167/tvst.13.11.14

Includes: Supplemental Content

Retina November 2024

Ocular Pharmacodynamics of Intravitreal Faricimab in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema

PDF

Cheikh Diack; Robert L. Avery; Chui Ming Gemmy Cheung; Karl G. Csaky; Leonid Gibiansky; Felix Jaminion; Ekaterina Gibiansky; Denise Sickert; Ivo Stoilov; Valerie Cosson; Katrijn Bogman
TAGS: diabetic macular edema, exudative age-related macular degeneration, faricimab, hypertension, vascular endothelial growth factor a, pharmacodynamics
Trans. Vis. Sci. Tech.. 2024; 13(11):13. https://doi.org/10.1167/tvst.13.11.13

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2023

Faricimab causes rapid and sustained intraocular suppression of Ang-2 and VEGF-A for up to 16 weeks in nAMD and DME

KATRIJN BOGMAN; Robert Avery; Ivo Stoilov; Cheikh Diack

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2633.

« Previous

Advertisement

Follow @ARVOtvst

TVST Home
Issues
Topics
For Authors

About
- Editorial Board

Online ISSN: 2164-2591

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2024 Association for Research in Vision and Ophthalmology.

Access Provided By:
MIT Libraries

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept